Molecular typing is predicated on molecular genetic screening and is not still routinely offered. Molecular subtypes and immunohistochemical surrogate markers on the tumors (HR, HER2, triple damaging) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-sixty seven can https://georgee208gpz8.blogsidea.com/profile